E. Lanari

Radiochemical and radiopharmacological properties of pirocarbotrat and other labeled charcoal dispersions: comparative studies in rats with NMU-induced mammary tumors.

M. Zubillaga, R. Caro, J. Boccio, 1998, Nuclear medicine and biology.

Pirocarbotrat: a new radiopharmaceutical for the treatment of solid tumors--comparative studies in N-nitrosomethylurea-induced rat mammary tumors.

M. Zubillaga, R. Caro, J. Boccio, 1997, Nuclear medicine and biology.

Use of colloids of chromic [32P] phosphate in treatment of solid tumors.

M. Zubillaga, R. Caro, J. Boccio, 1996, Nuclear medicine and biology.

Great particles [32P]chromic phosphate for treatment of solid tumors.

M. Zubillaga, R. Caro, J. Boccio, 1996, Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia.

Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR–ABL kinase domain mutations affect patient survival? First multicenter Argentinean study

M. Bianchini, R. Bengió, I. Larripa, 2011, Leukemia & lymphoma.